| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cfa15550f39524b1d94ab235b24ad657 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0682 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 |
| filingDate |
2009-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f0262209a8a45ac0a70d74ea3e6b79c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9358480fdb0b1b1f7340782647118bf0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b16c565d650c86658fa81f725165bed2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62bd7e709994492d5fee67fc0eaef9ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_159175b74370ce0286edd5c730313699
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eff5001badb7732d546853418840a652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5681d1e4b2aed1fa1cddcfa25c768055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c13f1f05fd704f30032a95d2133c6eb |
| publicationDate |
2009-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20090126226-A |
| titleOfInvention |
A method for producing insulin secreting cells through reprogramming from adult labia stem-derived adult cells and the use of the differentiated insulin secreting cells as cell therapy |
| abstract |
The present invention relates to a method for producing insulin secreting cells through reprogramming from adult labia major adult cells and the use of the differentiated insulin secreting cells as cell therapeutics. According to the present invention, when adult cells isolated from the labia minora were cultured in low glucose DMEM medium in a large amount and then cultured in ITS medium, the expression of endoderm markers is increased, and these cells are nicotinamide. When cultured in the added CM medium, it is possible to differentiate into insulin secreting cells. In addition, the present invention can provide a basis for mass production through a reprogramming process of cells that can be used for therapeutic purposes when diabetes occurs due to abnormal insulin secretion. |
| priorityDate |
2009-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |